The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma

被引：0
|
作者：
James O. Armitage
机构：
[1] University of Nebraska Medical Center,The Joe Shapiro Professor of Medicine, Department of Internal Medicine
来源：
Current Hematologic Malignancy Reports | 2011年 / 6卷
关键词：
Bleomycin; Hodgkin Lymphoma; Dacarbazine; Procarbazine; Classic Hodgkin Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.
引用
收藏
页码：155 / 156
页数：1
相关论文
共 50 条
  • [21] A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters
    Aksu, Aysegul
    Kucuker, Kadir Alper
    Solmaz, Serife
    Turgut, Bulent
    ANNALS OF HEMATOLOGY, 2024, 103 (03) : 813 - 822
  • [22] A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters
    Ayşegül Aksu
    Kadir Alper Küçüker
    Şerife Solmaz
    Bülent Turgut
    Annals of Hematology, 2024, 103 : 813 - 822
  • [23] Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy
    Henkenberens, Christoph
    Oehus, Ann-Kathrin
    Derlin, Thorsten
    Bengel, Frank
    Ross, Tobias L.
    Kuczyk, Markus A.
    Janssen, Stefan
    Christiansen, Hans
    von Klot, Christoph A. J.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (11) : 1006 - 1017
  • [24] PET-adapted salvage therapy for Hodgkin's lymphoma
    Laffon, Eric
    Marthan, Roger
    LANCET ONCOLOGY, 2015, 16 (05): : E197 - E198
  • [25] PET-adapted salvage therapy in Hodgkin's lymphoma
    Tirelli, Umberto
    Spina, Michele
    LANCET ONCOLOGY, 2015, 16 (03): : 239 - 240
  • [26] Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy
    Christoph Henkenberens
    Ann-Kathrin Oehus
    Thorsten Derlin
    Frank Bengel
    Tobias L. Ross
    Markus A. Kuczyk
    Stefan Janssen
    Hans Christiansen
    Christoph A. J. von Klot
    Strahlentherapie und Onkologie, 2020, 196 : 1006 - 1017
  • [27] A Pooled Analysis of Differences in Salvage Therapy for Early-Stage Hodgkin's Lymphoma with PET Directed Omission of Radiotherapy
    Shaikh, M. P.
    Pugliese, N.
    Alite, F., Jr.
    Picardi, M.
    Vargo, J. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S114 - S114
  • [28] PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial.
    Lorenzen, Sylvie
    Quante, Michael
    Rauscher, Isabel
    Slotta-Huspenina, Julia
    Becker, Karl Friedrich
    Weichert, Wilko
    Feith, Marcus
    Friess, Helmut
    Combs, Stephanie E.
    Weber, Wolfgang
    Haller, Bernhard
    Angele, Martin K.
    Albertsmeier, Markus
    Blankenstein, Christiane
    Kasper, Stefan
    Zimmermann, Jens Peter
    Alguel, Hana
    Schmid, Roland M.
    Schwaiger, Markus
    Siveke, Jens T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [29] Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma
    Carr, Rebecca A.
    Hsu, Meier
    Harrington, Caitlin A.
    Tan, Kay See
    Bains, Manjit S.
    Bott, Matthew J.
    Ilson, David H.
    Isbell, James M.
    Janjigian, Yelena Y.
    Maron, Steven B.
    Park, Bernard J.
    Rusch, Valerie W.
    Sihag, Smita
    Wu, Abraham J.
    Jones, David R.
    Ku, Geoffrey Y.
    Molena, Daniela
    ANNALS OF SURGERY, 2023, 277 (03) : E538 - E544
  • [30] Interim PET in Hodgkin Lymphoma
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) : 28N - +
12345